Matlock A Jeffries1, Madison Donica2, Lyle W Baker3, Michael E Stevenson4, Anand C Annan4, Mary Beth Humphrey5, Judith A James1, Amr H Sawalha6. 1. University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation, Oklahoma City. 2. Oklahoma Medical Research Foundation, Oklahoma City. 3. University of Oklahoma, Oklahoma City. 4. University of Oklahoma Health Sciences Center, Oklahoma City. 5. MPH: University of Oklahoma Medical Research Center and Veterans Affairs Medical Center, Oklahoma City. 6. University of Michigan, Ann Arbor.
Abstract
OBJECTIVE: To perform a genome-wide DNA methylation study to identify differential DNA methylation patterns in subchondral bone underlying eroded and intact cartilage from patients with hip osteoarthritis (OA) and to compare these with DNA methylation patterns in overlying cartilage. METHODS: Genome-wide DNA methylation profiling using Illumina HumanMethylation 450 arrays was performed on eroded and intact cartilage and subchondral bone from within the same joint of 12 patients undergoing hip arthroplasty. Genes with differentially methylated CpG sites were analyzed to identify shared pathways, upstream regulators, and overrepresented gene ontologies, and these patterns were compared with those of the overlying cartilage. Histopathology was graded by modified Mankin score and assessed for correlation with DNA methylation. RESULTS: We identified 7,316 differentially methylated CpG sites in subchondral bone underlying eroded cartilage, most of which (∼75%) were hypomethylated, and 1,397 sites in overlying eroded cartilage, 126 of which were shared. Samples clustered into 3 groups with distinct histopathologic scores. We observed differential DNA methylation of genes including the RNA interference-processing gene AGO2, the growth factor TGFB3, the OA suppressor NFATC1, and the epigenetic effector HDAC4. Among known susceptibility genes in OA, 32 were differentially methylated in subchondral bone, 8 were differentially methylated in cartilage, and 5 were shared. Upstream regulator analysis using differentially methylated genes in OA subchondral bone showed a strong transforming growth factor β1 signature (P = 1 × 10(-40) ) and a tumor necrosis factor family signature (P = 3.2 × 10(-28) ), among others. CONCLUSION: Our data suggest the presence of an epigenetic phenotype associated with eroded OA subchondral bone that is similar to that of overlying eroded OA cartilage.
OBJECTIVE: To perform a genome-wide DNA methylation study to identify differential DNA methylation patterns in subchondral bone underlying eroded and intact cartilage from patients with hip osteoarthritis (OA) and to compare these with DNA methylation patterns in overlying cartilage. METHODS: Genome-wide DNA methylation profiling using Illumina HumanMethylation 450 arrays was performed on eroded and intact cartilage and subchondral bone from within the same joint of 12 patients undergoing hip arthroplasty. Genes with differentially methylated CpG sites were analyzed to identify shared pathways, upstream regulators, and overrepresented gene ontologies, and these patterns were compared with those of the overlying cartilage. Histopathology was graded by modified Mankin score and assessed for correlation with DNA methylation. RESULTS: We identified 7,316 differentially methylated CpG sites in subchondral bone underlying eroded cartilage, most of which (∼75%) were hypomethylated, and 1,397 sites in overlying eroded cartilage, 126 of which were shared. Samples clustered into 3 groups with distinct histopathologic scores. We observed differential DNA methylation of genes including the RNA interference-processing gene AGO2, the growth factor TGFB3, the OA suppressor NFATC1, and the epigenetic effector HDAC4. Among known susceptibility genes in OA, 32 were differentially methylated in subchondral bone, 8 were differentially methylated in cartilage, and 5 were shared. Upstream regulator analysis using differentially methylated genes in OA subchondral bone showed a strong transforming growth factor β1 signature (P = 1 × 10(-40) ) and a tumor necrosis factor family signature (P = 3.2 × 10(-28) ), among others. CONCLUSION: Our data suggest the presence of an epigenetic phenotype associated with eroded OA subchondral bone that is similar to that of overlying eroded OA cartilage.
Authors: R Rollín; F Marco; J A Jover; J A García-Asenjo; L Rodríguez; L López-Durán; B Fernández-Gutiérrez Journal: Rheumatol Int Date: 2008-01-18 Impact factor: 2.631
Authors: Gehua Zhen; Chunyi Wen; Xiaofeng Jia; Yu Li; Janet L Crane; Simon C Mears; Frederic B Askin; Frank J Frassica; Weizhong Chang; Jie Yao; John A Carrino; Andrew Cosgarea; Dmitri Artemov; Qianming Chen; Zhihe Zhao; Xuedong Zhou; Lee Riley; Paul Sponseller; Mei Wan; William Weijia Lu; Xu Cao Journal: Nat Med Date: 2013-05-19 Impact factor: 53.440
Authors: Alvaro Del Real; Flor M Pérez-Campo; Agustín F Fernández; Carolina Sañudo; Carmen G Ibarbia; María I Pérez-Núñez; Wim Van Criekinge; Maarten Braspenning; María A Alonso; Mario F Fraga; Jose A Riancho Journal: Epigenetics Date: 2016-12-16 Impact factor: 4.528
Authors: Alvaro Del Real; Leyre Riancho-Zarrabeitia; Laura López-Delgado; José A Riancho Journal: Curr Osteoporos Rep Date: 2018-06 Impact factor: 5.096
Authors: Purva Singh; Samantha G Lessard; Piali Mukherjee; Brennan Rourke; Miguel Otero Journal: Ann N Y Acad Sci Date: 2020-09-25 Impact factor: 5.691